Filing Flows › Harvard Apparatus Regenerative Technology (HRGN) › Q2 2026 › vs Q1 2026
Harvard Apparatus Regenerative Technology (HRGN) Q2 2026 vs Q1 2026 (quarter over quarter)
Harvard Apparatus Regenerative Technology's revenue rose $188K (+83%) from $226K in Q1 2026 to $414K in Q2 2026.
Harvard Apparatus Regenerative Technology, Q2 2026: revenue $414K (+31% year over year), operating margin -408.7%, net loss $1.7M, operating cash flow −$569K. The chart draws each line against Q1 2026, the increases inside each band.
Every line
| Line | Q2 2026 | Q1 2026 | Change | % |
|---|---|---|---|---|
| Revenue | $414K | $226K | $188K | +83% |
| Net loss | $1.7M | $1.6M | $94K | +6% |
| Costs & expenses | $2.1M | $1.8M | $277K | +15% |
| Operating costs | $2.1M | $1.8M | $274K | +15% |
| Interest & other, net | $3K | −$5K | $8K | — |
| Cost of revenue | $391K | $206K | $185K | +90% |
| Research & development | $948K | $563K | $385K | +68% |
| General & admin | $751K | $1.0M | −$294K | -28% |
| Other operating costs | $16K | $18K | −$2K | -11% |
| Operating cash sources | $1.7M | $1.6M | $94K | +6% |
| Depreciation | $1K | $1K | $0 | 0% |
| Share-based compensation | $223K | $632K | −$409K | -65% |
| Working capital & other | $902K | $31K | $871K | 29× |
| Cash used in operations | $569K | $937K | −$368K | -39% |
| Net loss absorbed | $1.7M | $1.6M | $94K | +6% |
Questions
How much did Harvard Apparatus Regenerative Technology's revenue grow quarter over quarter in Q2 2026?
Harvard Apparatus Regenerative Technology's revenue rose $188K (+83%) from $226K in Q1 2026 to $414K in Q2 2026.